WT1 and neoplasm: Harris et al. [84] used yeast display assay and designed scTCRs with high affinity to two known tumor-associated antigens (overexpressed in tumor cells, but having low expression in healthy tissues): WT1 (acute myeloid leukemia) and MART (melanoma).